Original from: Quest Diagnostics
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Sentara Health Plans, the health plan division of Sentara Health, an integrated, not-for-profit health care delivery system, today announced a multi-year strategic collaboration designed to expand access to high-quality, affordable and comprehensive laboratory testing for members of Sentara Health Plans.
eginning January 1, 2025, Quest will be the exclusive independent national laboratory provider of clinical laboratory and anatomic pathology services for members of Sentara Health Plans, including commercial and its government programs. The agreement will apply to Sentara Health Plans members in Floridaand Virginia, including those in Sentara's Florida-serving AvMed business.
Sentara Health Plans and Quest will also collaborate on expanding Quest's patient service center network to support patient access in some geographies. In addition, the parties will consider avenues for educating Sentara Health Plans members and providers on the value of redirecting testing to Quest from higher-cost, out-of-network providers.
"Sentara Health Plans' strategic relationship with Quest promises to provide our Florida and Virginia members with innovative and comprehensive laboratory services," said Colin S. Drozdowski, Executive Vice President of Sentara and President of Sentara Health Plans. "Sentara Health Plans and Quest share a common goal to deliver quality and affordable care to our plan members."
"Health plans like Sentara value Quest as a strategic collaborator that can help them reduce healthcare costs while simultaneously enhancing access, innovation, and quality," said Leah D. Timmerman, Senior Vice President, Health Plans, Quest Diagnostics. "We look forward to helping Sentara Health Plans improve access and affordability for its members as we extend into parts of the southeastern U.S., particularly Virginia, where our presence has been limited."
